home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Parkinson's Gene Mutated in Cancer

  December, 11 2009 9:33
your information resource in human molecular genetics

PARK2, a gene commonly mutated in early-onset Parkinson's disease, is also mutated in glioblastoma, colon cancer and lung cancer, according to a new study published online in Nature Genetics. This suggests that while germline mutations in PARK2 cause neuronal defects that lead to Parkinson's disease, somatic mutations in PARK2 contribute to cancer.

Parkinson's disease is a common neurodegenerative disorder that affects more than four million people worldwide. Most cases of Parkinson's disease occur in people with no familial history of the disorder. However, 15% of cases occur in patients with familial history of the disease, many of whom carry mutations in known genes, including PARK2. Germline mutations in PARK2 lead to early-onset loss of specific neurons in the brain, but PARK2 is also known to be expressed in other tissues, including the lung, colon and testes.

Timothy Chan and colleagues report that they found deletions within both alleles of PARK2 in about 2% of glioblastoma -- an aggressive type of brain tumor -- and 6% of colon cancer samples. The scientists also identified mutations in the PARK2 gene in glioblastoma and lung cancer. Functional experiments show that these cancer-specific PARK2 mutations affect the ability of PARK2 protein to suppress cell growth.

Author contact:

Timothy Chan (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)
E-mail: chant@mskcc.org

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.